Science Share Discussion Threads

[oregano] 16/9/2015 16:00

the £100k of profit made by Leatherhead was after £355k of payments to the defined benefit pension fund, and £364k paid to one director. These won't occur again.

[sailing john] 16/9/2015 15:11

Looks like a great deal. Immediate £8m on revenue (+28%) with profit perhaps taking a little longer to accrue.

SJ

[oregano] 16/9/2015 15:00

it might take some time but I am sure they will get there. SAG was in this kind of state when MR bought his stake at 28p. I have been slightly under whelmed by the other deals - we never really find out how they perform. But this is great and gives them a (near) London presence.

[jombaston] 16/9/2015 14:33

You would certainly hope that it was a good price since it was a distressed sale. Relative to sales very cheap so as you say a question as to whether they can replicate margins

[oregano] 16/9/2015 11:18

i retract my last post! no reason why they won't earn similar margins to the group. upgrades will be huge. £2 next stop.

[oregano] 23/7/2015 14:11

true, they still have way too much cash and just acknowledged no acquisitions are likely. hopefully that 4p divi becomes 6.

[elgordo] 23/7/2015 13:37

Yeah, they really mailed that one in. Still, better to have bland but good results than exciting but bad ones...

[oregano] 23/7/2015 09:05

they could not have written a more bland statement than that. i wonder if he is trying to get shareholders outside the inner circle out. they were previously buying shares at 145ish.

[battlebus2] 24/6/2015 19:43

24 June 2015
Which technological innovations will shape our future?
Sagentia and MIT Technology Review partner to present 10 Breakthrough Technologies for 2015

Cambridge, MA – June 24, 2015 – Sagentia, a leading international science, product and technology development company, is today co-presenting with MIT Technology Review on the top breakthrough technologies for 2015. This is the third successive year that MIT Technology Review and Sagentia have partnered to evaluate the role of emerging technologies and their potential impact on future R&D.

The event will see Jason Pontin, Editor in Chief and Publisher of MIT Technology Review, introduce the 10 emerging technologies which it believes to be game-changing and highlight the problems that they could potentially address. He will be joined by Nick Collier, Chief Technology Officer at Sagentia, who will evaluate the technologies from an R&D perspective, discuss some of the key technology trends driving these advances and share insights into how to successfully bring new technology to market.

This year, the technologies include examples from the communications, medical, agriculture, and consumer markets and range from 3D virtual reality, to blood tests that detect very early-stage cancer. With the rise in the use of connected devices and the proliferation of internet usage, this year’s selections particularly highlight a range of innovations in communications technology including Apple Pay, Google’s Project Loon and the Internet of DNA.

“MIT Technology Review’s mission is to help our audiences understand a world shaped by technology and this event does just that. Each year, we highlight a range of recent technologies which we believe have the potential to provide real and lasting change in their particular fields” comments Jason Pontin, MIT Technology Review’s Editor in Chief and Publisher. “We are delighted that Sagentia, as a leading industry partner, work with us to provide informed critique into the technologies we identify and beyond – sharing insights into new areas they see every day when working on cutting edge science and technology projects. Together, we provide a forum for interested parties to discuss major breakthroughs and, importantly, to learn practical ideas on how to evaluate and commercialize new technologies.”

“MIT Technology Review does a great job in highlighting important developments in science and technology that could have a positive impact both on peoples’ lives and on the direction and effectiveness of future R&D. Science and technology is at the core of everything we do at Sagentia and so I’m really excited to be talking with Jason about these technologies and also sharing some of the latest trends and advances that we’re seeing in R&D and product development” remarks Dr. Nicholas Collier, Chief Technology Officer at Sagentia.

The event is free to attend and takes place this evening from 5:15pm-8:00pm at the MIT Bartos Auditorium in Cambridge, MA. For more information click here.



About MIT Technology Review

MIT Technology Review, which is wholly owned by MIT, creates award-winning technology-related editorial content on a variety of platforms for an audience of millions of business leaders, innovators, and thought leaders, in six languages and in 147 countries. At www.technologyreview.com, readers access daily news and analysis, and the award-winning MIT Technology Review magazine has set the standard for technology publications since 1899. In addition to producing engaging live events, the company manages the global entrepreneurial organization MIT Enterprise Forum.


About Sagentia

Sagentia is a global science, product and technology development company. Our scientists and engineers redefine what’s possible and help R&D groups achieve commercial return from their most complex technology projects. We have over 28 years’ experience and have successfully completed over 10,000 projects for start-up and global market leader clients alike, across the medical, industrial, oil & gas and consumer sectors.

Our services span the full product development lifecycle, from new concept generation and technology validation, through prototyping and full product development, to transfer to manufacture and sustainability. Sagentia employs over 150 scientists, engineers and market experts and is part of the Sagentia Group, with headquarters in Cambridge, UK and offices in London, Guildford, Boston, Houston and Dubai.

For further information visit us at: www.sagentia.com or email [e-mail]

2015

[battlebus2] 26/5/2015 12:45

5K trade at 150 could be more buy backs.

[battlebus2] 22/5/2015 16:27

Interesting but i doubt TRT would want to sell given the progress they're making.

[battlebus2] 22/5/2015 15:55

Good to see a few buys, still a long way to go these imv, real spread is 150/153 but i suspect the next buy will see a tick up again...

[battlebus2] 22/5/2015 10:34

Thanks elgordo, that's reassuring, the one day it might be useful could be useful to us all.

[elgordo] 22/5/2015 09:46

Quite an interesting post-AGM write-up on "another" site (substitute site name in URL) -

eye-eye-eye.co.uk/news-opinion/richard-beddard/sagentia-agm%3A-when-too-much-cash-problem?context=LSE:SAG

"Ratcliffe says... He’s always said the company should not have listed in the first place, but since it is, he’s not inclined to take it private. One day it might be useful."

[battlebus2] 19/5/2015 22:11

X dividend on Thursday.

[anumidium] 07/5/2015 23:02

I was thinking in terms of the average exchange rate through the period. I guess that is the best estimate of the impact on revenues though the timing of contracts might change that.

[oregano] 05/5/2015 15:22

the currency is less favourable this year than it was at Dec. So unsure if that is the reason.

But i can't see any other reason why the shares have been so strong. I wonder if this is material? TT sounds quite bullish at the end. "game changing" chat.

hxxp://www.sagentia.com/News/Press-Releases-And-News/2015/Sagentia-and-TT-Electronics-sign-multiyear-licensing-deal.aspx

We probably get a trading update at the AGM on the 21st.

[anumidium] 03/5/2015 07:15

GBP/USD exchange rate has been favourable so far this period, should boost results considerably. Probably the recent strength reflects this. Expect things will remain the same so long as it looks like the Fed will raise rates before the BoE.

[battlebus2] 16/4/2015 16:45

Looks like a bit of profit taking but i notice every trade is reported twice, maybe the company is gathering them up :))

[battlebus2] 14/4/2015 10:18

160 next stop on the chart :))

[battlebus2] 13/4/2015 15:23

New recent highs, they tried to lower the bid to entice a seller or two but alas it only attracted buyers :))

[battlebus2] 13/4/2015 08:40

Someone paying over the odds for 4k..

[battlebus2] 07/4/2015 08:05

Indeed it was , another 125k at 145p....

[battlebus2] 02/4/2015 15:47

Looks like more shares bought back.